CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven
Clinical Trial Readouts on the Horizon for NASH Monotherapies
October 05, 2018
Seedhouse, Steven
Investing in Best-in-Class Emerging Pharmaceuticals
October 21, 2016
Moussatos, Liana
Handpicked Stocks in Emerging Pharmaceuticals
November 24, 2014
Moussatos, Liana
Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014
Xu, Y. Katherine
Outlook For Property & Casualty Insurers: Michael Hallett - Fox-pitt, Kelton Inc
November 14, 2003
Hallett, Michael
Consumer Product Companies: William Chappell Jr. - Suntrust Robinson Humphrey
April 01, 2003
Chappell, William
Hospitals & Healthcare Facilities: Frank Morgan - Jefferies & Company Inc
March 17, 2003
Morgan, Frank G.
Enterprise Infrastructure Software: Sarah Mattson - Rbc Capital Markets
January 07, 2003
Mattson, Sarah
Consumer & Industrial Services: Alexander Paris Jr. - Barrington Research Associates Inc
April 22, 2002
Outlook For Specialty Chemicals: Timothy Gerdeman - Lehman Brothers
October 15, 2001
Wendell Perkins - Johnson Asset Management
October 15, 2001
Specialty Pharmaceuticals: Ken Laudan - Robinson Humphrey Company Llc
April 09, 2001
Stephen Tang - Millennium Cell Inc (mcel)
April 09, 2001
Etailing : Lauren Cooks Levitan - Robertson Stephens
March 02, 2000
